Fabhalta

Active Ingredient(s): Iptacopan Hydrochloride
FDA Approved: * December 5, 2023
Pharm Company: * NOVARTIS
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fabhalta 200 mg Oral Capsule
NDC: 0078-1189
Labeler:
Novartis Pharmaceuticals Corporation